5-iodo-6-amino-1,2-benzopyrone has been researched along with iniparib in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Battaile, KP; Beletskaya, I; Chirgadze, NY; Gebremeskel, S; Gordon, R; Lam, R; Pai, EF; Qiu, W; Romanov, V; Rottapel, R; Thompson, C; Vodsedalek, J; Voytyuk, O | 1 |
| Kirsten, E; Kun, E | 1 |
2 other study(ies) available for 5-iodo-6-amino-1,2-benzopyrone and iniparib
| Article | Year |
|---|---|
Insights into the binding of PARP inhibitors to the catalytic domain of human tankyrase-2.
Topics: Benzamides; Benzimidazoles; Bridged Bicyclo Compounds, Heterocyclic; Catalytic Domain; Crystallography, X-Ray; Enzyme Inhibitors; Humans; Models, Molecular; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Protein Conformation; Pyrimidinones; Quinazolines; Tankyrases | 2014 |
Cancer cell selectivity of 5-iodo-6-aminobenzopyrone (INH2BP) and methyl-3,5-diiodo-4(4'-methoxyphenoxy) benzoate (DIME).
Topics: Antineoplastic Agents; Benzamides; Cell Division; Cells, Cultured; Coumarins; Enzyme Inhibitors; Fibroblasts; Humans; Iodobenzoates; Phenyl Ethers; Poly(ADP-ribose) Polymerase Inhibitors; Tumor Cells, Cultured | 2000 |